Health ❯ Medical Research ❯ Clinical Trials
PD-1 Therapy Case Studies Cancer Therapies
FDA fast-tracked the six-month custom CRISPR therapy that corrected KJ’s CPS1 mutation, enabling normal protein metabolism with reduced drug support.
